The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study
NCT04016181 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 800
Last updated 2025-06-25
Summary
To prospectively study novel blood and lung biomarkers of disease activity in patients with IPF and other interstitial lung disease with the aims of prognostic modelling and disease clustering
Conditions
Sponsors & Collaborators
-
University of Edinburgh
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-06-14
- Primary Completion
- 2026-12-31
- Completion
- 2036-12-01
More Related Trials
-
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
NCT02315586 ·Status: COMPLETED
-
A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis
NCT05895409 ·Status: RECRUITING
-
Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England)
NCT01134822 ·Status: COMPLETED
-
A Study to Test Different Imaging Techniques in Patients With Different Types of Interstitial Lung Disease
NCT05492994 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessment of Peripheral Endothelial Function in Idiopathic Pulmonary Fibrosis
NCT02594059 ·Status: COMPLETED ·Phase: NA
-
Functional and Structural Lung Imaging in Chronic Obstructive Pulmonary Disease
NCT04966221 ·Status: UNKNOWN
-
Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis
NCT03104322 ·Status: COMPLETED ·Phase: NA
-
Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients
NCT02058602 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
NCT00470327 ·Status: RECRUITING
-
Development of Airway Absorption Sampling Methods
NCT04494334 ·Status: WITHDRAWN
-
Influence of Socioeconomic and Environmental Factors on the Natural History of Idiopathic Pulmonary Fibrosis
NCT04619199 ·Status: UNKNOWN ·Phase: NA
-
Genentech Xenon MRI Idiopathic Pulmonary Fibrosis
NCT04071769 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Digital Auscultation Test - IPF Data Collection
NCT03503188 ·Status: COMPLETED ·Phase: PHASE4
-
Pulmonary Fibrosis Foundation Patient Registry
NCT02758808 ·Status: COMPLETED
-
Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry
NCT00212511 ·Status: WITHDRAWN
-
Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
NCT00373841 ·Status: RECRUITING
-
Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)
NCT00258544 ·Status: ACTIVE_NOT_RECRUITING
-
Monitoring and Evaluation Study of Project ECHO for ILD
NCT05455437 ·Status: UNKNOWN
-
Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis
NCT01718990 ·Status: COMPLETED
-
A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung Fibrosis
NCT07080125 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period
NCT03261037 ·Status: COMPLETED ·Phase: NA
-
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
NCT01071707 ·Status: COMPLETED
-
Advancing Prevention of Pulmonary Fibrosis
NCT04564183 ·Status: ACTIVE_NOT_RECRUITING
-
Image and Model Based Analysis of Lung Disease
NCT03764163 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases
NCT00005317 ·Status: COMPLETED